CDSCO Approves AstraZeneca’s Trastuzumab Deruxtecan-Pertuzumab Combo For HER2-Positive Breast Cancer
AstraZeneca Pharma India (AZPIL) has received approval from the Central Drugs Standard Control Organisation (CDSCO) for an additional…
Browsing Tag